Search alternatives:
teer decrease » greater decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1101
-
1102
Transgenic expression of SPDEF in prostate epithelium decreased prostate carcinogenesis.
Published 2014“…Data represent mean ± SD. A <i>p</i> value<0.01 is shown with (**) and <i>p</i> value<0.05 is shown with (*). …”
-
1103
-
1104
-
1105
-
1106
-
1107
-
1108
-
1109
Damage accumulation decreases elongation rates and displaces growth equilibrium.
Published 2019“…<p>All panels depict MG1655 wild-type <i>E</i>. <i>coli</i>. (A) Exposure to phototoxic damage led to decreasing elongation rates in all treatment levels (length of exposure, every 2 min: 70 ms, 700 ms, 1 s, 1.5 s, 3 s). …”
-
1110
Processive receptor methylation compromises adaptation and decreases signaling noise.
Published 2013“…(C) Increasing processivity also decreases the magnitude of fluctuations in <i>a</i>(<i>t</i>) in the adapted state around the mean value <i>a</i><sub>0</sub>. …”
-
1111
-
1112
Decreased respiratory performance of children and adolescents with myelomeningocele who use a wheelchair – preliminary data
Published 2019“…MMC showed lower values for forced vital capacity, forced expiratory volume at the first second, forced expiratory flow (25–75%), maximal voluntary ventilation, and isometric peak for shoulder flexors and adductors compared to healthy participants. This indicated a decreased vital capacity, respiratory muscle endurance, and shoulder muscle strength.…”
-
1113
CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line.
Published 2014“…Immortalized HBECs with (A) lenti-<i>KRas</i><sup>V12</sup>, (B) lenti-<i>KRas</i><sup>V12</sup> and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i><sup>V12</sup>, sh<i>p53</i>, and <i>myc</i> overexpression. …”
-
1114
-
1115
-
1116
-
1117
-
1118
-
1119
-
1120